This report contains market size and forecasts of Skin and Soft Tissue Infection Treatment in Global, including the following market information:
Global Skin and Soft Tissue Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Skin and Soft Tissue Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Skin and Soft Tissue Infection Treatment include Merck, Wockhardt Limited, Atox Bio Inc., Durata Therapeutics (Teva), Basilea Pharmaceutica AG, Melinta Therapeutics and Takeda Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Skin and Soft Tissue Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Skin and Soft Tissue Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Skin and Soft Tissue Infection Treatment Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Anti-Fungal Agents
Others
Global Skin and Soft Tissue Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Skin and Soft Tissue Infection Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Global Skin and Soft Tissue Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Skin and Soft Tissue Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Skin and Soft Tissue Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Skin and Soft Tissue Infection Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Wockhardt Limited
Atox Bio Inc.
Durata Therapeutics (Teva)
Basilea Pharmaceutica AG
Melinta Therapeutics
Takeda Pharmaceutical